Celgene Corp.
(NASDAQ : CELG)

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.00%129.650.0%$2878.82m
BNGOBioNano Genomics, Inc. 0.00%8.430.0%$1523.88m
GILDGilead Sciences, Inc. 0.00%63.331.0%$663.26m
AMGNAmgen, Inc. 0.00%245.491.3%$599.79m
CRSPCRISPR Therapeutics AG 0.00%199.880.6%$544.48m
ALXNAlexion Pharmaceuticals, Inc. 0.00%156.702.0%$501.25m
NVAXNovavax, Inc. 0.00%127.4392.9%$480.66m
REGNRegeneron Pharmaceuticals, Inc. 0.00%517.932.7%$480.32m
ILMNIllumina, Inc. 0.00%376.353.5%$384.71m
BIIBBiogen, Inc. 0.00%275.841.7%$366.50m
VRTXVertex Pharmaceuticals, Inc. 0.00%225.551.9%$350.25m
BNTXBioNTech SE 0.00%101.590.0%$316.33m
SRPTSarepta Therapeutics, Inc. 0.00%90.3213.8%$296.56m
OCGNOcugen, Inc. 0.00%2.220.0%$276.18m
EDITEditas Medicine, Inc. 0.00%76.147.9%$256.07m

Company Profile

Celgene Corporation is a global integrated biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases in patients with limited treatment options. There are hundreds of clinical trials at major medical centers evaluating compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma (MM), myelodysplastic syndromes (MDS), chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), pancreatic cancer, non-small lung cancer and melanoma. In addition, several compounds are being evaluated as therapies for serious inflammatory diseases such as psoriasis and psoriatic arthritis.